April 25, 2018 / 7:45 AM / a month ago

BRIEF-Beijing SL Pharmaceutical sees FY 2018 H1 net profit up 35 pct to 65 pct

April 25 (Reuters) - Beijing SL Pharmaceutical Co Ltd

* Says it sees FY 2018 H1 net profit to increase by 35 percent to 65 percent, or to be 314.2 million yuan to 384.1 million yuan

* Says FY 2017 H1 net profit was 232.8 million yuan

* Comments that increased sales of new products as main reason for the forecast

Source text in Chinese:goo.gl/Qgub3e

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below